Эффекты энтерального питания, содержащего эйкозапентаеновую и γ-линоленовую кислоты и антиоксиданты, у больных, находящихся на искусственной вентиляции легких с тяжелым сепсисом и септическим шоком

1. Heys SD, Walker LG, Smith I et al. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer. Ann Surg 1999; 4: 467–77.
2. Al-Saddy NM, Blackmore CM, Bennet ED. High fat, low carbohydrate, Enteral feeding lowers PaCO2 and reduce the period on ventilation in artificially ventilated patients. Intensive Care Med 1989; 15: 290–5 .
3. Gadek JE, De Michele SJ, Karlstad MD et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in patients with acute respiratory distress syndrome. Crit Care Med 1999; 27: 1409–20.
4. Bernard CR, Vincent GL, Laterre PF et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699–709.
5. Panacek EA, Marshall JC, Albertson TE et al. Efficacy and safety of the monoclonal antitumor necrosis factor antibody F(ab[prime])2 fragment afelimomab in patients with severe sepsis and elevated interleukin- 6 levels. Crit Care Med 2004; 32: 2173–82.
6. Heller A, Koch T, Scmeck J et al. Lipid mediators in inflammatory disoders. Drugs 1998; 55: 487–96.
7. Whelan J, Broughton KS, Kinsella JE. Thecomparative effects of dietary alpha-linolenic acid and fish oil on 4- and 5-series leukotriene generation and neutrophil function Lipids 1991; 26: 119–26.
8. Lee TH, Hoover RL, Williams JD et al. Effects of dietary enrichment with eicosapentaeonic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985; 312: 1217–24.
9. Mancuso P, Whelan J, DeMichele S et al. Effect of eicosapentaeonic acid and gamma-linolenic acid on lung permeability and alveolar macrophage eicosanoids synthesis in endotoxic rats. Crit Care Med 1997; 25: 523–32.
10. Mancuso P, Whelan J, DeMichele S et al. Dietary fish oil and bourage oil suppress intrapulmonary proinflammatory eicosanoids biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats. Crit Care Med 1997; 25: 1198–206.
11. Ziboth VA, Fletcher MP. Dose-dependent effects of dietary gammalinolenic acid-enriched oils of human polymorphonuclear-neutrophil biosynthesis of leukotriene B sub 4. Am Clin Nutr 1992; 55: 39–45.
12. Kenler AS, Swalls WS, Driscoll DF et al. Early enteral feeding in postsurgical cancer patients: Fish oil structured lipid-based polymeric formula versus a standart polymeric formula. Ann Surg 1996; 223: 316–33.
13. Murray MJ, Svingen BA, Yakish TL et al. Effects of endotoxin on pigs prefed ω-3 vs. ω-6 fatty-enriched diets. Am J Physiol 1993; 265: E920–7 .
14. Grimminger FC, Wahn H, Mayer K et al. Impact of arachnoidic acid versus eicosapentaenoic acid on endotoxin-induced lung vaskular leakage. Am J Respir Crit Care Med 1997; 155: 513–9 .
15. Lo C, Chiu KC, Fu M et al. Fish oil modulates macrophage P44/P42 mitogen-activated protein kinase activity induced by lipopolysaccharide JPEN J Parenter Enter Nutr 2000; 24: 159–63.
16. Pacht ER, DeMichele SJ, Nelson JL et al. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid and antioxidants reduces alveolar inflammatory mediators and protein influx in patient with acute respiratory distress syndrome. Crit Care Med 2003; 31: 491–500.
17. Heller AR, Rossel T, Gottschlich B et al. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 2004; 111: 611–6 .
18. Palombo JB, DeMichele SJ, Lydon E et al. Rapid modulation of lung and liver macrophage phospholipids fatty acids in endotoxemic rats by continuous Enteral feeding with n-3 and gamma-linolenic acids. Am J Clin Nutr 1996; 63: 208–19.
19. Mayer R, Gokrosch S, Fegbeutel C et al. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med 2003; 167: 1321–8.
20. Barton RG, Wells CL, Carlson A et al. Dietary omega-3 fatty acids decrease mortality and Kupffer cell prostaglandin E2 production in a rat model of chronic sepsis. J Trauma 1991; 31: 768–74.
21. Johnson JA, Grisworld JA, Muakkassa FF. Essential fatty acids influence survival in sepsis. J Trauma 1993; 35: 128–31.
22. Mascioli EA, Iwasa Y, Trimbo S et al. Endotoxin challenge after menhaden oil diet: Effect on survival of guinea pigs. Am J Clin Nutr 1989; 49: 277–82.
23. Mascioli EA, Leader L, Flores E et al. Enhanced survival to endotoxin in guinea pigs fed IV fish oil emulsion. Lipids 1988; 23: 623–5 .
24. Dellinger RP, Carlet JM, Mansur H et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: 858–72.
25. Rivers E, Nguyen B, Murphy JR et al. Early goal-directed therapy in treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368–77.
26. Bone RC, Balk RA, Cerra PB et al. ACCP/SCCM Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovate therapies in sepsis. Chest 1992; 10: 1644–55.
27. Bernard CR, Margolis BD, Shanies HM et al. Extended Evaluation of Recombinant Human Activated Protein C United States Trial (ENHANCE US). A single-arm, phase 3B, multicenter study of drotrecogin alfa (activated) in severe sepsis. Chest 2004; 125: 2206–16.
28. Donaldson-Andersen J, Fitzsimmons L. Metabolic requirments of the critically ill, mechanically ventilated trauma patients: Measured versus predicted energy expenditure. Nutr Clin Pract 1998; 13: 25–31.
29. Esteban A, Alia I, Tobin MJ et al. Effect of spontaneous breathing trial duration on outcome of attempts to discontinue mechanical ventilation. Spanish Lung Failure Collaborative Group. Am J Respir Crit Care Med 1999; 159: 512–8 .
30. Pontes-Arruda A. The effect of Enteral feeding ith eicosapentaenoic acid, gamma-linolenic acid and antioxidants in patient with sepsis. Critical Care 2005; 9 (Suppl. 1): P363.
31. O'Brien PC, Fleming PR. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549–56.
32. Rosner B. Fundamentals of Biostatistics. Second Edition. Boston PWS Publishers, 1986.
33. Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457–81.
34. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep 1966; 50: 163–70.
35. Newcombe RG. Interval estimation for the difference between independent proportions: Comparison of eleven methods. Stat Med 1998; 17: 873–90.
36. Armitage P, Berry G. Statistical Methods in Medical Research Third Edition, London, Blackwell, 1994.
37. Bernard GR, Artigas A, Brigham KL et al. The American-European Consensus Conferences on ARDS. Am J Respir Crit Care Med 1994; 149: 818–24.
38. Palombo JD, DeMichele SJ, Patricia B et al. Effect of short-term Enteral feeding with eicosapentaenoic acid and gamma-linolenic acid on alveolar macrophage eicosanoids synthesis and bacterial function in rats. Crit Care Med 1999; 27: 1908–15.
39. Bulger EM, Helton WS, Clinton CM et al. Enteral vitamin E supplementation inhibits the cytokine response to endotoxin. Arch Surg 1997; 132: 1337–41.
40. Seeger W, Zielger A, Wolf HR. Serum alphatocopherol levels after high-dose Enteral vitamin E administration in patients with acute respiratory failure. Intensive Care Med 1987; 13: 395–400.
41. Bulgeer EM, Jurkovich GJ, Gentiello LM et al. Current clinical options for the treatment and management of acute respiratory distress syndrome. J Trauma 2000; 48: 562–72.
42. Vincent J-L, Bernard G, Beate R et al. Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment. Crit Care Med 2005; 33: 2266–77.
43. Silva E, Pedro MA, Sogayar ACB et al. Brazilian Sepsis Epidemiological Study (BASES Study). Crit Care 2004; 8: R251–60.
44. Bone RC: Isaac Newton, sepsis, SIRS and CARS. Crit Care Med 1996; 24: 1125–8 .

A.Pontes-Arruda, A.M.Albuquerque Aragao, J.D.Albuquerque

Crit Care Med 2006; 9 (34): 2325–33.